000			01959 a2200505 4500
005			20250516110842.0
264		0	_c20130225
008			201302s 0 0 eng d
022			_a1095-6859
024	7		_a10.1016/j.ygyno.2012.08.037 _2doi
040			_aNLM _beng _cNLM
100	1		_aGould, Natalie
245	0	0	_aA phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. _h[electronic resource]
260			_bGynecologic oncology _cDec 2012
300			_a506-10 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCarboplatin _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aDocetaxel
650	0	4	_aFallopian Tube Neoplasms _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aInjections, Intraperitoneal
650	0	4	_aMiddle Aged
650	0	4	_aOvarian Neoplasms _xdrug therapy
650	0	4	_aPaclitaxel _xadministration & dosage
650	0	4	_aPeritoneal Neoplasms _xdrug therapy
650	0	4	_aTaxoids _xadministration & dosage
700	1		_aSill, Michael W
700	1		_aMannel, Robert S
700	1		_aThaker, Premal H
700	1		_aDiSilvestro, Paul A
700	1		_aWaggoner, Steven E
700	1		_aYamada, S Diane
700	1		_aArmstrong, Deborah K
700	1		_aFracasso, Paula M
700	1		_aWalker, Joan L
773	0		_tGynecologic oncology _gvol. 127 _gno. 3 _gp. 506-10
856	4	0	_uhttps://doi.org/10.1016/j.ygyno.2012.08.037 _zAvailable from publisher's website
999			_c22072900 _d22072900